Psychometric Validation of the Hepatitis C Symptom and Impact Questionnaire (HCV-SIQv4) in a Diverse Sample of Adults with Chronic Hepatitis C Virus Infection Treated with an Interferon-free Simeprevir-containing Regimen

Journal of Health Economics and Outcomes Research
Andrew TriggJane Scott

Abstract

Hepatitis C virus (HCV) infection and its treatments are associated with significant symptoms, side effects and impact on patients functioning. The Hepatitis C Symptom and Impact Questionnaire version 4 (HCV-SIQv4) was developed according to FDA Patient Reported Outcomes (PRO) Guidance, for evaluating chronic HCV infection and its treatment. This study evaluated the psychometric properties and clinically important change (CIC) thresholds of the measure. PRO data were pooled from three Phase IIb and III trials evaluating interferon-free simeprevir-containing regimens for treatment of chronic HCV infection. Scale range adequacy, reliability, validity, responsiveness and CIC thresholds were assessed incorporating knowledge of the appropriate measurement model. Data from 437 patients were analyzed. Stage of liver disease was associated with symptom severity and functioning at baseline. Reliability was acceptable (test-retest ICC ≥0.7) for most scores except the Gastrointestinal and Integumentary domains. Convergent validity was observed between HCV-SIQv4 scores and concurrent measures of conceptual similarity. Greater symptom severity and worse impact scores were associated with liver cirrhosis, depression, severe fatigue and healt...Continue Reading

References

Mar 1, 1997·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·P M Fayers, D J Hand
Jul 27, 1999·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·J E WareG L Davis
Dec 29, 2000·Archives of Physical Medicine and Rehabilitation·E M Andresen
Feb 24, 2001·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·L KleinmanD Revicki
Oct 11, 2002·Journal of Gastroenterology·Motoki IwasakiShosuke Suzuki
Oct 31, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Leonard B Seeff
Mar 26, 2003·The American Journal of Gastroenterology·Christopher A K Y ChongMurray Krahn
Apr 5, 2005·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Diane WildUNKNOWN ISPOR Task Force for Translation and Cultural Adaptation
May 17, 2006·Annals of Internal Medicine·Gregory L ArmstrongMiriam J Alter
May 27, 2006·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Michael R CharltonStephen A Harrison
Sep 5, 2006·American Journal of Alzheimer's Disease and Other Dementias·Rebecca E ReadyJanet Grace
Sep 26, 2006·Health and Quality of Life Outcomes·Mark J Atkinson, Richard D Lennox
Oct 24, 2006·Parkinsonism & Related Disorders·Janet GraceJoseph H Friedman
Jun 20, 2008·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Hla-Hla TheinMurray D Krahn
Mar 1, 1979·Psychological Bulletin·P E Shrout, J L Fleiss
Jul 9, 2009·Journal of Clinical Nursing·Myra SgorbiniDebra Jackson
Dec 17, 2009·Gastroenterology Nursing : the Official Journal of the Society of Gastroenterology Nurses and Associates·Michelle Kinder
Feb 20, 2010·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Lidwine B MokkinkHenrica C W de Vet
Jun 18, 2011·Liver International : Official Journal of the International Association for the Study of the Liver·Markus CornbergStefan Zeuzem
Jul 20, 2011·Psychological Methods·Kenneth A Bollen, Shawn Bauldry
Apr 25, 2012·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·K W WyrwichUNKNOWN Industry Advisory Committee of International Society for Quality of Life Research (ISOQOL)
Aug 8, 2012·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Ben van HoutA Simon Pickard
Nov 23, 2012·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Khayriyyah Mohd HanafiahSteven T Wiersma
Nov 28, 2012·BMC Infectious Diseases·S ZaltronF Castelli
Jan 5, 2013·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Bryce B ReeveZeeshan Butt
Jun 25, 2013·Journal of the Neurological Sciences·Y C LearmonthR W Motl
Sep 6, 2013·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Roger T AndersonDennis A Revicki
Jun 12, 2014·Health and Quality of Life Outcomes·Kathleen RosaJane Scott
Apr 8, 2015·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Shivani K Mhatre, Sujit S Sansgiry
Oct 30, 2015·BMC Research Notes·Maria Laura AvilaBrian M Feldman
Dec 26, 2015·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Eric LawitzJames Witek
Jan 23, 2016·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Paul KwoJames Witek
Apr 21, 2016·Journal of Medical Virology·Lan S WangIra M Jacobson
Aug 28, 2016·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Zobair M YounossiLinda Henry
Jan 1, 2016·Therapeutic Innovation & Regulatory Science·Cheryl D Coon, Joseph C Cappelleri

❮ Previous
Next ❯

Software Mentioned

OPTIMIST1
OPTIMIST2
SAS Analysis System
IMPACT

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Evidence-based Complementary and Alternative Medicine : ECAM
Byoung-Kab KangJu Ah Lee
Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine
Jie Yang, Mi-qu Wang
Journal - American Intra-Ocular Implant Society
J M GoogeR J Olson
© 2021 Meta ULC. All rights reserved